These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16509469)

  • 21. Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes.
    Shin JY; Shin YG; Chung CH
    Diabetes Care; 2006 Jul; 29(7):1664-6. PubMed ID: 16801598
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased levels of osteoprotegerin in hemodialysis patients.
    Avbersek-Luznik I; Malesic I; Rus I; Marc J
    Clin Chem Lab Med; 2002 Oct; 40(10):1019-23. PubMed ID: 12476941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.
    Kraj M; Owczarska K; Sokołowska U; Centkowski P; Pogłód R; Kruk B
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):454-64. PubMed ID: 16314829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS; Hegedüs LM; Beck-Nielsen H; Abrahamsen B
    Calcif Tissue Int; 2003 Sep; 73(3):210-6. PubMed ID: 14667132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum osteoprotegerin levels in healthy controls and cancer patients.
    Lipton A; Ali SM; Leitzel K; Chinchilli V; Witters L; Engle L; Holloway D; Bekker P; Dunstan CR
    Clin Cancer Res; 2002 Jul; 8(7):2306-10. PubMed ID: 12114435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Novel active analogues of vitamin D3 for therapy of secondary hyperparathyroidism due to long-term hemodialysis in patients with chronic kidney failure].
    Kobayashi T; Nishii Y
    Nihon Rinsho; 1991 Dec; 49 Suppl():715-9. PubMed ID: 1808341
    [No Abstract]   [Full Text] [Related]  

  • 28. The relation between serum levels of osteoprotegerin and postoperative epidural fibrosis in patients who underwent surgery for lumbar disc herniation.
    Sen O; Gokcel A; Kizilkilic O; Erdogan B; Aydin MV; Sezgin N; Yalcin O; Caner H; Altinors N
    Neurol Res; 2005 Jun; 27(4):452-5. PubMed ID: 15949247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone cytokines and renal osteodystrophy in peritoneal dialysis patients.
    Mesquita M; Wittersheim E; Demulder A; Dratwa M; Bergmann P
    Adv Perit Dial; 2005; 21():181-4. PubMed ID: 16686314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
    Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
    Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum osteoprotegerin and renal osteodystrophy.
    Coen G; Ballanti P; Balducci A; Calabria S; Fischer MS; Jankovic L; Manni M; Morosetti M; Moscaritolo E; Sardella D; Bonucci E
    Nephrol Dial Transplant; 2002 Feb; 17(2):233-8. PubMed ID: 11812872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
    Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
    Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of intravenous and subcutaneous calcitriol in the treatment of secondary hyperparathyroidism.
    Boran M; Cetin S
    Nephron; 1998 Sep; 80(1):119-20. PubMed ID: 9730731
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.
    Rogers A; Eastell R
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6323-31. PubMed ID: 16105967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes.
    Xiang GD; Xu L; Zhao LS; Yue L; Hou J
    Diabetes; 2006 Jul; 55(7):2126-31. PubMed ID: 16804084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endurance running acutely raises plasma osteoprotegerin and lowers plasma receptor activator of nuclear factor kappa B ligand.
    Ziegler S; Niessner A; Richter B; Wirth S; Billensteiner E; Woloszczuk W; Slany J; Geyer G
    Metabolism; 2005 Jul; 54(7):935-8. PubMed ID: 15988704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity.
    Ugur-Altun B; Altun A; Gerenli M; Tugrul A
    Diabetes Res Clin Pract; 2005 Jun; 68(3):217-22. PubMed ID: 15936463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?
    Masi L; Simonini G; Piscitelli E; Del Monte F; Giani T; Cimaz R; Vierucci S; Brandi ML; Falcini F
    J Rheumatol; 2004 May; 31(5):986-91. PubMed ID: 15124262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.
    Nitta K; Akiba T; Uchida K; Otsubo S; Takei T; Yumura W; Kabaya T; Nihei H
    Nephrol Dial Transplant; 2004 Jul; 19(7):1886-9. PubMed ID: 15128884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.